Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Starts & Stops: ICS' Emblok Medtronic's Arctic Front, Abbott's Absorb, Boston Scientific's S-ICD

Executive Summary

Starts & Stops is a regular feature highlighting Medtech Insight editors' picks of noteworthy medtech clinical trial initiations, completions and suspensions each month. Over the last month, 31 new trials started, 25 trial were completed, one trial was "reinitiated," and six trials were terminated or suspended, according to meddevicetracker.

Advertisement

Related Content

EuroPCR 2017: TAVR Continues To Beat Surgery; Bioabsorbable Stents Not Going Away
OUS Approvals Analysis: Small Companies Dominate International Approvals In April
Earnings Winners and Losers: JNJ, MMSI, ABT, ZBH, SNN, EW, Plus Round-Up
Abbott To Restrict Absorb To Registries In Europe For At Least A Year
'All-Comers' Trial Finds Increased Risk Of Thrombosis With Abbott's Absorb BVS Stent
Starts & Stops: Boston Scientific Starts, Stops, And Finishes TAVR Trials
Cerebral Embolic Protection For TAVR: Start-Ups Compete

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

MT104753

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel